Cancer/Gene Therapy - Melanoma Issues

"Medical Management of Stage IV Malignant Melanoma: Medical Issues."

Published in Cancer Weekly, February 27th, 1995

According to the author's abstract of an article published in Cancer, "Background: Stage IV melanoma is defined by TNM staging as any tumor, any node, and M1, the presence of distant metastasis. The prognosis of Stage IV melanoma is grim. The expectation for 5-year survival is less than 10%. Methods: The experience with single-agent chemotherapy, combination chemotherapy, and high dose chemotherapy with autologous bone marrow transplantation support are reviewed, as are the results of treatment with interferon and interleukin-2. Results: Chemotherapy with single agents yields up to a 20% response rate. More aggressive treatments with chemotherapy...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-02-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry